Grail, Inc. (GRAL) at a glance

Grail, Inc. (GRAL) is a mid-cap Healthcare company. It trades at $76.23, with a -253.2% profit margin and revenue growth of 28.1%. It does not pay a dividend. Vestovix scores it 54/100 overall. Its strongest dimension is Growth (75/100) and its weakest is Income (40/100).

Price
$76.23
Market cap
$2.57B
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$30.82 to $118.84
Vestovix Score54/ 100How this works
Value
48
Growth
75
Income
40
Safety
52
Momentum
51

Other Healthcare stocks

See all